vee.
Research workspace
FOR RESEARCH USE ONLY. Not for human consumption. Independent directory — we do not sell peptides.

Research library.

Independent information for a more informed research process.

Research papers

5 sourced papers

Each paper shows its evidence type and limits. Clinical drug trials do not validate research-market products.

BPC-157

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

HSS Journal, 2025 · Systematic review; mostly animal studies

Reviews proposed orthopedic uses and finds the evidence is largely preclinical.

Limits
A review cannot establish efficacy; human clinical evidence is limited.
Read on PubMed
TB-500 / thymosin beta-4

The effect of thymosin treatment of venous ulcers

Annals of the New York Academy of Sciences, 2010 · Phase 2 placebo-controlled human study

Tested topical full-length thymosin beta-4 for venous ulcers and reports a possible healing signal at one concentration.

Limits
Full-length topical thymosin beta-4 is not the same as products sold as TB-500.
Read on PubMed
GHK-Cu

Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper

Wound Repair and Regeneration, 1994 · Randomized placebo-controlled human study

Reported greater diabetic ulcer closure with a topical GHK-Cu gel plus standard wound care.

Limits
Specific to one topical formulation and wound care; not evidence for other uses.
Read on PubMed
Semaglutide

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England Journal of Medicine, 2021 · Randomized clinical trial in adults

The STEP 1 trial evaluated semaglutide with lifestyle intervention for weight management.

Limits
Applies to the studied population and supervised approved-drug protocol, not research-market products.
Read on PubMed
Tirzepatide

Tirzepatide Once Weekly for the Treatment of Obesity

The New England Journal of Medicine, 2022 · Randomized clinical trial in adults

The SURMOUNT-1 trial studied tirzepatide for weight management in adults without diabetes.

Limits
Results apply to the trial population and protocol, not every group or product.
Read on PubMed

Peptide-content voices

Not ranked or endorsed

Selected public creators who regularly cover peptides. Listing order is not a popularity ranking, and their views are not scientific verification.

Adam Boender

thepeptidepulse.com

Hosts The Peptide Pulse podcast about therapeutic peptides, research, and longevity.

Disclosure
Site describes clinician-education and practice-growth services.
Official site

Gregory Gopman

peptalkshow.com

Hosts PepTalk, covering peptides, GLP-1s, regulation, and performance.

Disclosure
Site includes editorial recommendations and resources.
Official site

John Garrett, RN

peptidesexplained.info

Peptides Explained offers peptide and GLP-1 educational episodes and resources.

Disclosure
Associated resources display a vendor discount code.
Official site

Tyna Moore, ND

drtyna.com

Site and podcast include GLP-1 and peptide education.

Disclosure
Promotes a paid membership and educational offerings.
Official site

Farhan Tahir, MD

youthfulpeptide.com

Hosts evidence and opinion discussions about repair peptides and incretin therapies.

Disclosure
Other commercial relationships are unknown.
Official site

William A. Seeds, MD

foundations.seeds.md

Offers a peptide-therapy course for clinicians.

Disclosure
Promotes a paid course.
Official site